Summit Therapeutics Inc. (SMMT) Debt Components
- 2024-09-30: Notes Payable, CurrentUSD $24.50M; Notes Payable, Related Parties, CurrentUSD (m); Notes Payable, Related Parties, NoncurrentUSD (m).
- 2024-09-16: Notes Payable, CurrentUSD $24.50M; Notes Payable, Related Parties, CurrentUSD (m); Notes Payable, Related Parties, NoncurrentUSD (m).
- 2024-06-30: Notes Payable, CurrentUSD $100.00M; Notes Payable, Related Parties, CurrentUSD (m); Notes Payable, Related Parties, NoncurrentUSD (m).
- 2023-12-31: Notes Payable, CurrentUSD $0.00; Notes Payable, Related Parties, CurrentUSD (m); Notes Payable, Related Parties, NoncurrentUSD (m).
Summit Therapeutics Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Notes Payable, Related Parties, Current USD | Notes Payable, Related Parties, Noncurrent USD |
|---|---|---|---|
| 2024-09-30 | $24.50M | (m) | (m) |
| 2024-09-16 | $24.50M | (m) | (m) |
| 2024-06-30 | $100.00M | (m) | (m) |
| 2023-12-31 | $0.00 | (m) | (m) |
| 2023-09-30 | $100.00M | (m) | (m) |
| 2023-06-30 | $0.00 | (m) | (m) |
| 2023-03-31 | (m) | $0.00 | $100.00M |
| 2022-12-31 | $19.77M | (m) | (m) |
| 2022-12-31 | (m) | $19.77M | $494.54M |
| 2022-06-30 | (m) | (m) | $25.31M |
| 2022-03-31 | (m) | (m) | $25.05M |
| 2021-12-31 | (m) | $0.00 | $0.00 |
| 2021-03-31 | (m) | $54.96M | (m) |
| 2020-12-31 | (m) | $0.00 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |